In addition, PERK-mediated upregulation of fibroblast growth factor 2 (FGF2), vascular endothelial growth factor (VEGF), and interleukin-6 (IL-6) and downregulation of antiangiogenic cytokines remarkably promote tumor growth and vascularization [196]. The gene discussed is EIF2AK3; the disease is neoplasm.